Healthcare Thermoplastics: Trilliant™ HC

Composition of the highest governance body and its committees To our knowledge, within Avient's operations the right to freedom of association and collective bargaining continue to remain compliant with all statutory requirements.

This Policy reinforces Avient’s position on the promotion of free and fair competition and the Company’s commitment to comply with all applicable laws and regulations.

Exercise or Base Price of Option Awards (column (i)) Grant Date Fair Value of Stock and Option Awards (column (j)) Narrative Disclosure Relating to the 2018 Summary Compensation Table and the 2018 Grants of Plan-Based Awards Table Outstanding Equity Awards at 2018 Fiscal Year-End Exercise Price Expiration Date Market Value of Shares or Units of Stock That Have Not Vested Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights that Have Not Vested (j) Stock Awards Equity Incentive Plan Awards: Number of Securities Underlying Unearned Options Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights that Have Not Vested (i) Number of Shares or Units of Stock That Have Not Vested Number of Underlying Unexercised Options (#) Unexercisable Number of Securities Underlying Options (#) Exercisable Option Awards Number of Securities Underlying Unexercised Options (#) Exercisable (column (b)) Number of Securities Underlying Unexercised Options (#) Unexercisable (column (c)) Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (column (d)) Option Exercise Price (column (e)) Option Expiration Date (column (f)) Number of Shares or Units of Stock That Have Not Vested (column (g)) Market Value of Shares or Units of Stock That Have Not Vested (column (h)) Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (column (i)) Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested (column (j)) 2018 Option Exercises and Stock Vested Option Awards Stock Awards Acquired on Exercise Value Realized on Exercise Acquired on Vesting Value Realized on Vesting Option Awards (columns (b) and (c)) Stock Awards (columns (d) and (e)) 2018 Nonqualified Deferred Compensation Aggregate Executive Registrant Aggregate Aggregate Aggregate Balance at Contributions Contributions Earnings Withdrawals/ Balance at in Last FY in Last FY in Last FY Distributions Last FYE (1) ($)(2) ($)(3) ($)(4) ($) ($)(1)(5) Potential Payments Upon Termination or Change of Control Summary of Potential Payments Management Continuity Agreements Executive Severance Plan Annual Plan Long-Term Incentive Awards Retirement Benefits Payments and Benefits Upon Termination — As of the End of Fiscal Year 2018 CEO Pay Ratio Disclosure CEO Annual Total Compensation for 2018: $6,127,920 Median Employee Annual Total Compensation for 2018: $48,056 Ratio of CEO to Median Employee Annual Total Compensation for 2018: 128:1 How the Median Employee was Determined in 2017 Compensation Committee Interlocks and Insider Participation Policy on Related Person Transactions Risk Assessment of the Compensation Programs Compensation Committee Report The Compensation Committee of the Board of Directors MISCELLANEOUS MISCELLANEOUS PROVISIONS Voting at the Meeting not Shareholder Proposals MISCELLANEOUS Proxy Solicitation We will furnish without charge to each person from whom a proxy is being solicited, upon written request of any such person, a copy of the Annual Report on Form 10-K of the Company for the fiscal year ending December 31, 2018, as filed with the SEC, including the financial statements and schedules thereto.

The sale of Products or the providing of samples or developmental material shall not, by implication or otherwise, convey any license under any intellectual property right relating to the compositions and/or applications of the Products, sample, or developmental material, as applicable.

The sale of Products or the providing of samples or developmental material shall not, by implication or otherwise, convey any license under any intellectual property right relating to the compositions and/or applications of the Products, sample, or developmental material, as applicable.

The sale of Products or the providing of samples or developmental material shall not, by implication or otherwise, convey any license under any intellectual property right or rights related thereto, including but not limited to protections on trade secrets, relating to the compositions and/or applications of the Products, sample, or developmental material, as applicable.

The sale of Products or the providing of samples or developmental material shall not, by implication or otherwise, convey any license under any intellectual property right relating to the compositions and/or applications of the Products, sample, or developmental material, as applicable.

The sale of Products or the providing of samples or developmental material shall not, by implication or otherwise, convey any license under any intellectual property right relating to the compositions and/or applications of the Products, sample, or developmental material, as applicable.

The sale of Products or the providing of samples or developmental material shall not, by implication or otherwise, convey any license under any intellectual property right relating to the compositions and/or applications of the Products, sample, or developmental material, as applicable.